Abstract
Tuberculosis is caused byMycobacterium tuberculosis, an intracellular pathogen residing in macrophages. Cell mediated immune (CMI) and delayed type of hypersensitive (DTH) responses play a pivotal role in providing protection to the host. The most important cell is the CD4 T lymphocyte, which is divided into TH1 and TH2 subsets depending on the type of cytokines produced. TH1 cells produce the cytokines interferon-gamma and interleukin-2, which are important for activation of antimycobacterial activities and essential for the DTH response. Grange opines that the immune response in an individual with tuberculous infection gets ‘locked in’ to one or other pattern of response viz. TH1 or TH2 response, the latter response leading to tissue damage and progression of disease.
Stanford and co-workers conducted several studies on the effectiveness ofMycobacterium vaccae, as an immunotherapeutic agent for tuberculosis. It is non-pathogenic in humans and is thought to be a powerful TH1 adjuvant. A series of small studies pointed thatM. vaccae has a beneficial effect and there is enough evidence now to show that its use as an immunotherapeutic agent, as an adjunct to chemotherapy in the treatment of tuberculosis especially at a time when drug resistance is rampant, appears promising.
Key Words: Tuberculosis, Drug-Resistance, Immunotherapy, T Cell Responses
Full Text
The Full Text of this article is available as a PDF (268.6 KB).
References
- 1.Stanford J.L., Grange J.M. The promise of immunotherapy for tuberculosis. Respir. Med. 1994;88:3–7. doi: 10.1016/0954-6111(94)90166-X. [DOI] [PubMed] [Google Scholar]
- 2.Corlan E., Marica C., Macavei C., Stanford J.L., Stanford C.A. Immunotherapy withMycobacterium vaccae in the treatment of tuberculosis in Romania. 1. Newly-diagnosed pulmonary disease. Respir. Med. 1997;91:13–19. doi: 10.1016/S0954-6111(97)90132-3. [DOI] [PubMed] [Google Scholar]
- 3.Grange J.M. Immunotherapy: A new strategy for tuberculosis control. Respir. Med. 1997;91:1–4. doi: 10.1016/S0954-6111(97)90130-X. [DOI] [PubMed] [Google Scholar]
- 4.Jain N.K. Drug resistance in India: A tragedy in the making. Ind. J. Tub. 1992;39:145–148. [Google Scholar]
- 5.Farid R., Etemadi A., Mehvar M., Stanford J.L., Dowlati Y., Velayati A.A. Mycobacterium vaccae immunotherapy in the treatment of multi-drug-resistant tuberculosis: A preliminary. Report. Im. J. Med. Sci. 1994;19(182):37–39. [Google Scholar]
- 6.Stanford J.L., Stanford C.A. Immunotherapy withMycobacterium vaccae and the treatment of tuberculosis. J. Appl. Bacteriol. 1996;81:81S–86S. [PubMed] [Google Scholar]